Biotechnology, Pharmaceutical and Life Science Reports and Courses

Main Pages

Best Selling Products

BioNewsCast Press Release Distribution Service

3rd Annual Stability Testing Conference

Next-Gen Sequencing Trends 2009

Competitor Analysis: c-MET/HGF Inhibitors

The Japanese Pharmaceutical Market 2008-2023

New Products

Japanese Pharmaceutical Market 2009-2024

3rd Annual Lyophilisation Conference

The Global Bioinformatics Market: Market size, forecasts and company profiles

Pharmaceutical Mergers and Acquisitions (PH133)

Pharmaceutical Speaker Programs (PH134) Measuring ROI and Communicating Value

Strategic Clinical Sourcing (PH125)) Managing Costs and CROs

The Global Analgesics Market 2009-2024

Competitor Analysis: Coagulation Factors

Competitor Analysis: PDGF-R Agonists and Antagonists

World Market for Addiction Disorders, 2009-2016

BioPortfolio | Kalorama Reports | Global Tuberculosis Strategies

Global Tuberculosis Strategies

The importance, danger and costs of tuberculosis in the 21st century cannot be understated or underestimated. Though nearly extinct in the 20th century, Over 1.6 billion people worldwide suffer from tuberculosis, and it is now presenting a major crisis in public health circles.

In addition to the basic pathology and complications of tuberculosis, there are primarily three focal points for the development of strategy in this area: potential market, epidemiology (tuberculosis patient trends) and technology.

Kalorama Information's Global Tuberculosis Strategies, authored by Kalorama Information analyst Kenneth G. Krul, PhD, covers these points in detail and presents the most authoritative look at the global tuberculosis threat, strategies to combat tuberuclosis, and the market opportunities that can be created in tuberculosis treatement. As part of its coverage, the report includes:

Extensive Tuberculosis Etiology necessary to underatnd this unique disease.

Epidemiologic Statistics including 30 Tables of Incidence, Prevalance and Mortality Statistics by Region and by Type of Tuberculosis.

Theoretical Market Sizes for Testing and Treatment by Region and by Type of Tuberculosis (MDR and non-MDR).

Complete overview of Tuberculosis Screening Procedures.

Review of Products used for treatment of Tuberculosis.

A Glossary of Important Terms.

A truly global round-up, the report focuses in detail on the following regions:

Africa

The Americas

Eastern Mediterranean

Europe

Southeast Asia

Western Pacific

Jun 1, 2007

250 Pages

PDF Format
Table of Contents
Price: $3,995.00 / €2,672.66

BioPortfolio uses RBS Worldpay Secure Server for credit card transactions